FI962769A - (E)-2'deoxi-2'(fluormetylen)cytidinmonohydrat - Google Patents

(E)-2'deoxi-2'(fluormetylen)cytidinmonohydrat Download PDF

Info

Publication number
FI962769A
FI962769A FI962769A FI962769A FI962769A FI 962769 A FI962769 A FI 962769A FI 962769 A FI962769 A FI 962769A FI 962769 A FI962769 A FI 962769A FI 962769 A FI962769 A FI 962769A
Authority
FI
Finland
Prior art keywords
fluoromethylene
cytidinmonohydrat
deoxi
cytidine
deoxy
Prior art date
Application number
FI962769A
Other languages
English (en)
Finnish (fi)
Other versions
FI962769A0 (sv
FI114396B (sv
Inventor
Richard Eugene Donaldson
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI962769A0 publication Critical patent/FI962769A0/sv
Publication of FI962769A publication Critical patent/FI962769A/sv
Application granted granted Critical
Publication of FI114396B publication Critical patent/FI114396B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI962769A 1994-01-07 1996-07-05 Förfarande för framställning av (E)-2'-deoxi-2'-(fluormetylen)sytidinmonohydrat FI114396B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17895294A 1994-01-07 1994-01-07
US17895294 1994-01-07
PCT/US1994/014648 WO1995018815A1 (en) 1994-01-07 1994-12-13 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
US9414648 1994-12-13

Publications (3)

Publication Number Publication Date
FI962769A0 FI962769A0 (sv) 1996-07-05
FI962769A true FI962769A (sv) 1996-07-05
FI114396B FI114396B (sv) 2004-10-15

Family

ID=22654587

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962769A FI114396B (sv) 1994-01-07 1996-07-05 Förfarande för framställning av (E)-2'-deoxi-2'-(fluormetylen)sytidinmonohydrat

Country Status (20)

Country Link
EP (1) EP0738273B1 (sv)
JP (1) JPH09511227A (sv)
KR (1) KR100330328B1 (sv)
CN (1) CN1043231C (sv)
AT (1) ATE186732T1 (sv)
AU (1) AU684604B2 (sv)
CA (1) CA2179987C (sv)
DE (1) DE69421721T2 (sv)
DK (1) DK0738273T3 (sv)
ES (1) ES2141330T3 (sv)
FI (1) FI114396B (sv)
GR (1) GR3032614T3 (sv)
HU (1) HU217849B (sv)
IL (1) IL112242A (sv)
MX (1) MX9500363A (sv)
NO (1) NO306409B1 (sv)
NZ (1) NZ279030A (sv)
TW (1) TW397838B (sv)
WO (1) WO1995018815A1 (sv)
ZA (1) ZA9512B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222614T3 (es) 1997-11-12 2005-02-01 Mitsubishi Chemical Corporation Derivados de purina y medicina que los contiene como ingrediente activo.
DE60006663T2 (de) 1999-05-11 2004-10-07 Mitsubishi Chem Corp Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA898567B (en) * 1988-11-15 1990-08-29 Merrell Dow Pharma Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives
FI95269C (sv) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co Antivirala, ytterst vattenlösliga, stabila, kristallina salter av 2',3'-dideoxiinosinmonohydrat, 2',3'-dideoxi-2',3'-didehydrotymidinmonohydrat och 2',3'-dideoxi-2'-fluorinosinhemihydrat
JPH0615557B2 (ja) * 1990-02-19 1994-03-02 ヤマサ醤油株式会社 ２’―デオキシ―２’―メチリデンシチジンの２水和物結晶
NZ251886A (en) * 1992-05-12 1996-02-27 Merrell Dow Pharma Ribonucleotide reductase inhibitors and their production

Also Published As

Publication number Publication date
HUT75055A (en) 1997-03-28
AU1553295A (en) 1995-08-01
DK0738273T3 (da) 2000-04-17
NO962848L (no) 1996-09-06
MX9500363A (es) 1998-04-30
EP0738273B1 (en) 1999-11-17
ES2141330T3 (es) 2000-03-16
TW397838B (en) 2000-07-11
DE69421721D1 (de) 1999-12-23
HU217849B (hu) 2000-04-28
FI962769A0 (sv) 1996-07-05
AU684604B2 (en) 1997-12-18
IL112242A (en) 2000-08-31
WO1995018815A1 (en) 1995-07-13
CA2179987C (en) 1999-01-19
CN1141045A (zh) 1997-01-22
NO962848D0 (no) 1996-07-05
HU9601848D0 (en) 1996-09-30
NZ279030A (en) 1997-05-26
JPH09511227A (ja) 1997-11-11
FI114396B (sv) 2004-10-15
IL112242A0 (en) 1995-03-30
ZA9512B (en) 1995-09-11
KR100330328B1 (ko) 2002-12-05
GR3032614T3 (en) 2000-05-31
ATE186732T1 (de) 1999-12-15
NO306409B1 (no) 1999-11-01
CN1043231C (zh) 1999-05-05
EP0738273A1 (en) 1996-10-23
CA2179987A1 (en) 1995-07-13
DE69421721T2 (de) 2000-04-27

Similar Documents

Publication Publication Date Title
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
BRPI0411900A (pt) compostos antivirais e métodos
NO963239D0 (no) Klorpyrimid-mellomprodukter
PT755249E (pt) Utilizacao de inibidores da reaccao de maillard para o tratamento de doenca com base em amiloidose
BR0115055A (pt) Terapia de combinação compreendendo agentes anticonvulsantes e antidiabéticos
CA2002648A1 (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
FI962769A0 (sv) (E)-2'deoxi-2'(fluormetylen)cytidinmonohydrat
MY124071A (en) Treatment of viral disease in swine
BR9811643A (pt) Suplementação quìmica de osso
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
DK178188D0 (da) Antivirusmiddel
DE69836087D1 (de) Kortikalknochenimplantat für wirbelfusion nach smith-robinson
DK0459176T3 (da) Oligophosphater med antiviral virkning
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
AR015724A1 (es) La utilizacion de un inhibidor del intercambiador entre na+ y h+ para la preparacion de un medicamento destinado al tratamiento o a la profilaxia deenfermedades del sistema nervioso central.
ES2085023T3 (es) Procedimientos para la produccion de zidovudina.
SE9403861D0 (sv) Novel medicinal use
BR9906931A (pt) Triazepinonas, processo para sua preparação e sua aplicação terapêutica
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
ITCA950008A0 (it) Impiego di combinaqzioni di analoghi di nucleosidi nella terapia delleinfezioni dell'aids.
ITCA950010A0 (it) Combinazioni di pirrolobenzotiazepine con analoghi di nucleosidi per la terapia dell'aids.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114396

Country of ref document: FI